Clinical Trials – The Bloodline with LLS
Clinical Trials - The Bloodline with LLS
Podcast Description
A Podcast for Patients and Caregivers
Podcast Insights
Content Themes
The podcast focuses on a variety of critical cancer-related topics, including CAR T-cell therapy, challenges in treating acute myeloid leukemia (AML), and the evolving landscape of myeloma treatment. Episodes delve into specific conditions and treatments, featuring interviews that answer pressing questions from patients and caregivers, such as eligibility criteria and side effects of new therapies.
A podcast for patients and caregivers

Myeloproliferative neoplasms (MPNs) are rare blood cancers that alter how the body produces blood cells, requiring individualized care. In this episode, Catriona Jamieson, MD, PhD, of the University of California San Diego, shares the latest breakthroughs in MPN research, from detecting disease progression earlier to developing targeted, personalized therapies.
We explore MPN subtypes, the role of genetic testing, and current and emerging therapies. Whether you are navigating polycythemia vera (PV), essential thrombocythemia (ET), or myelofibrosis (MF), this conversation offers practical insights into today’s care landscape and new reasons for hope.
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
- Myeloproliferative neoplasms (MPN)
- Acute myeloid leukemia (AML)
- MPN Research Foundation
- MPN Research Foundation and Blood Cancer United Exclusive Clinical Trial Navigation
- Dynamic Internation Prognostic Scoring System (DIPSS/DIPPS Plus)
- MPN-SAF (Myeloproliferative Neoplasm Symptom Assessment Form)
- Mutation-Enhanced International Prognostic Scoring System
- World Health Organization (WHO) MPN Classification
- Clinical Trial Support Center
Additional Blood Cancer United Support Resources:
- Information Specialists
- Free Nutrition Consultations
- Free telephone/web patient programs
- SHARE web series
- Online videos
- Free booklets
- Young Adult Resources
- Young Adult Online Chat
- Caregiver support
- Caregiver Workbook
- Caregiver Chat
- Support groups
- Patient Community
- Medical Debt Case Management Program
- Financial support
- Survivorship Workbook
- Advocacy and Public Policy
- Mental Health Resources
Episode supported by Novartis Pharmaceuticals Corporation; PharmaEssentia USA Corporation; and Takeda Oncology.
The post Myeloproliferative Neoplasms (MPNs): New Therapies, New Hope first appeared on The Bloodline with Blood Cancer United Podcast.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.